Company / Working Capital
IQVIA Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$2.1B
FY2025
5-year range
-$2.1B / -$478.0M
FY2021-FY2025
Trend
-85.2%
vs FY2024
Sector context
#154 of 160
Health Care
What the data says
Among 160 Health Care companies, IQVIA is in the bottom 4% for working capital. Working Capital has declined for 5 consecutive years, from $532M in FY2020 to -$2.1B in FY2025.
Based on SEC 10-K filings.
-$2.1B in FY2025.
Declined from -$895M to -$2.1B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 160This company -$2.1B Sector average $757.1M
▼
-375.9% below sector average
Key checks
Key Insights
- IQVIA's working capital has declined for 5 consecutive years.
- In FY2025, working capital decreased 85.2% year-over-year.
- Ranks #154 out of 160 companies in the Health Care sector.
- Peak working capital was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 20.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.1B | -85.2% |
| FY2024 | -$1.1B | -26.0% |
| FY2023 | -$895.0M | -49.9% |
| FY2022 | -$597.0M | -24.9% |
| FY2021 | -$478.0M | -189.8% |
| FY2020 | $532.0M | +193.9% |
| FY2019 | $181.0M | -46.8% |
| FY2018 | $340.0M | -14.6% |
| FY2017 | $398.0M | -37.0% |
| FY2016 | $632.0M | -22.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026